U.S. Food Stock News

Toro earnings beat and guidance update put professional segment in focus Toro (TTC) recently reported first quarter fiscal 2026 earnings that exceeded analyst expectations and raised full year guidance, putting fresh attention on how its professional segment and recent acquisition are shaping the stock. See our latest analysis for Toro. The current share price of $94.04 sits alongside a 17.3% year to date share price return. The 1 year total shareholder return of 37.0% contrasts with weaker 3...

Why the Carlyle partnership matters for SEI Investments (SEIC) The expanded partnership between SEI Investments (SEIC) and Carlyle centers on giving wealth and retirement clients greater access to institutional-style private market strategies, including new model portfolios and defined contribution focused solutions. See our latest analysis for SEI Investments. SEI Investments’ latest share price of $90.79 comes after a 17.89% 1 month share price return and a 9.37% year to date gain, while...

In the first quarter of 2026, Prosperity Bancshares reported net interest income of US$321.15 million and net income of US$116.27 million, while net charge-offs rose to US$41.31 million from US$2.70 million a year earlier. Alongside higher credit costs, the bank continued capital returns through share repurchases and maintained its quarterly dividend, signaling ongoing balance-sheet management priorities. Next, we’ll examine how the surge in net charge-offs and related credit costs may...

GeneDx Holdings (WGS) opened Q1 2026 with recent quarterly revenue of US$120.99 million in Q4 2025 and a basic EPS loss of US$0.61, alongside trailing 12 month revenue of US$427.54 million and a basic EPS loss of US$0.73. Over the last year, revenue has moved from US$95.64 million in Q4 2024 to US$120.99 million in Q4 2025, while quarterly EPS has swung between a profit of US$0.38 in Q2 2025 and losses of up to US$0.61. This sets up an earnings story that investors may review in terms of how...

In the first quarter of 2026, C.H. Robinson Worldwide reported revenue of US$4,012.93 million and net income of US$147.23 million, while continuing a long-running buyback that has retired 79.30 million shares for about US$6.19 billion since 2007, including 1.23 million shares repurchased this year. At the same time, investors are focused on rising competitive pressure from Amazon’s newly opened supply chain services and legal uncertainty from the Montgomery v. C.H. Robinson Supreme Court...

Veeco Instruments Inc. reported first-quarter 2026 results with sales of US$158.34 million, down from US$167.29 million a year earlier, and swung from an US$11.95 million net profit to a US$0.324 million net loss. At the same time, Veeco announced over US$250 million in new orders for systems used in Indium Phosphide laser manufacturing, underlining growing demand from silicon photonics and hyperscale data centers. We’ll now examine how Veeco’s new US$250 million Indium Phosphide laser...

In April 2026, Aehr Test Systems reported a record US$41 million production order from a major hyperscale AI customer and a year-over-year jump in its unfilled order backlog to US$38.70 million, even as it completed an at-the-market equity program and posted a quarterly loss on weaker revenue. This combination of large AI-related orders, growing backlog, fresh equity capital, and recent insider selling highlights both the company’s expanding opportunities in semiconductor burn-in technology...

DiamondRock Hospitality (DRH) is back in focus after first quarter 2026 results topped analyst expectations, with management lifting full year revenue and EBITDA guidance and increasing its emphasis on hotel sales and share repurchases. See our latest analysis for DiamondRock Hospitality. The stock has gained clear momentum around these updates, with a 13.07% 1 month share price return and 16.67% year to date share price return, alongside a 49.70% 1 year total shareholder return. This...

In late April 2026, Builders FirstSource reported first-quarter results showing sales of US$3,287.08 million, a net loss of US$47.41 million, and issued full-year 2026 net sales guidance of US$14.60 billion to US$15.60 billion while launching a new US$500 million share repurchase authorization and continuing to signal interest in acquisitions. Management highlighted an ongoing focus on using free cash flow to fund value-added acquisitions and buybacks even as weaker quarterly performance...

Event context and recent performance snapshot Strive Asset Management (ASST) stock has drawn attention after recent trading, with a 0.9% one day gain, an 8.0% move over the past week, and a 69.3% rise over the past month. See our latest analysis for Strive Asset Management. At a share price of $16.51, Strive Asset Management has a 30-day share price return of 69.33% and a year-to-date share price return of a 4.52% decline, suggesting recent momentum after earlier weakness. If this kind of...

Wondering whether Amprius Technologies at US$21.40 is still worth your attention after a rapid run up, or if the price has already moved ahead of the fundamentals? The stock has returned 8.7% over the last week, 33.8% over the last month, 144.9% year to date, and a very large 1 year return of 822.4%, which puts recent trading firmly on most investors' radar. Recent coverage has focused on Amprius Technologies as interest in battery and electrification related companies has increased, with...

First Bancorp recently reported first-quarter 2026 results, with net interest income rising to US$107.12 million and net income to US$46.66 million, while also disclosing US$1.40 million in net charge-offs for the period. The bank also strengthened its governance and industry expertise by adding alternative-investments specialist Kate Nevin and higher-education leader Peter Hans to its Board of Directors. With earnings growth and expanded board expertise in focus, we’ll now examine how these...

Integer Holdings (NYSE:ITGR) has begun a comprehensive review of its business and capital structure. The Board is assessing options that may include a sale, merger, or other business combination. The review follows heightened external interest in the company and involves financial and legal advisors. The process is focused on assessing ways to maximize value for existing shareholders. Integer Holdings, traded on the NYSE under the ticker ITGR, operates in the medical technology space,...

Tronox Holdings plc recently confirmed a quarterly dividend of US$0.0500 per share payable on July 8, 2026, with both the ex-dividend and record dates set in the past on May 11, 2026. Around the same time, Truist downgraded Tronox to Sell, highlighting concerns about cost pressures and near-term earnings guidance despite the dividend affirmation. With Truist’s downgrade foregrounding near-term earnings pressures, we’ll now examine how this development reshapes Tronox’s existing investment...

Heartland Express, Inc. previously reported first-quarter 2026 results showing sales of US$176.26 million versus US$219.42 million a year earlier, with net loss narrowing to US$4.82 million and no share repurchases during the period under its existing buyback programs. Alongside the smaller loss, investors also learned that long-time executive David P. Millis retired as President of Millis Transfer while remaining on Heartland’s board, a leadership shift that may influence how integration...

Stock performance snapshot and why FTI Consulting is on investors’ radar FTI Consulting (FCN) has drawn investor attention after recent price moves, with the stock closing at US$166.95. Returns over the past week, month and past 3 months have all been negative. See our latest analysis for FTI Consulting. The recent pullback, including a 1-day share price return of negative 0.65% and a 30-day share price return of negative 8.93%, sits against a 5-year total shareholder return of 17.65%. This...

Supernus Pharmaceuticals (SUPN) is back in focus after reporting first quarter 2026 results that topped Wall Street earnings and revenue expectations, with Qelbree, GOCOVRI, ZURZUVAE, and ONAPGO playing key roles. See our latest analysis for Supernus Pharmaceuticals. Supernus Pharmaceuticals’ share price has been broadly steady in recent months, with a 2.7% 1 month share price decline and a roughly flat 90 day move. However, a 59.0% 1 year total shareholder return points to strong longer term...

Context for Ross Stores stock Ross Stores (ROST) has drawn investor attention recently as its stock screens show a market value of about US$72.8b and reported annual revenue of US$22.8b with net income of US$2.1b. See our latest analysis for Ross Stores. The share price has gained clear traction recently, with a 20.16% 90 day share price return and 24.45% year to date, while the 1 year total shareholder return of 62.2% points to strong, sustained momentum. If Ross Stores strong run has you...

Event driven snapshot of Acadia Healthcare Company (ACHC) Acadia Healthcare Company (ACHC) shares have been volatile recently, with a 9% decline over the past week offset by gains of about 5% over the month and roughly 86% in the past 3 months. See our latest analysis for Acadia Healthcare Company. At a share price of $25.27, Acadia Healthcare Company's recent share price return shows sharp short term swings but strong recent momentum, with a 5.47% 30 day gain and 86.49% 90 day gain. This...

If you are wondering whether Keysight Technologies at around US$355.93 is a bargain or already pricing in a lot of optimism, the starting point is to understand what the current valuation is actually implying. The stock has shown strong recent momentum, with returns of 7.1% over 7 days, 22.2% over 30 days, 72.3% year to date, 142.9% over 1 year, 148.9% over 3 years and 156.2% over 5 years. This naturally raises questions about how much upside or risk is now baked into the price. Recent...

CleanSpark (NasdaqCM:CLSK) is accelerating a shift from pure Bitcoin mining toward hosting AI and high performance computing data centers. The company is in advanced talks with a potential investment grade hyperscaler tenant for direct data center capacity. New greenfield AI data center construction is underway in Georgia, backed by CleanSpark’s existing power portfolio. Management is publicly addressing concerns around data center power and water usage as part of this transition. For you...

Amgen (NasdaqGS:AMGN) has been selected by the FDA as one of only two companies to run proof of concept trials under the new real time clinical trials initiative. The program is designed to enable continuous clinical development with real time data sharing between companies and the FDA. The collaboration focuses on reshaping how trials are designed, monitored, and adapted during the development of new therapies. Amgen is a large biotechnology company with a broad portfolio of therapies and...

In early May 2026, Entergy Corporation filed a follow-on equity offering of US$2.18 billion in common stock, shortly after reporting first-quarter 2026 revenue of US$3,187.63 million and net income of US$384.92 million. An interesting aspect is that Entergy is seeking to raise a very large amount of new equity just days after posting higher year-on-year sales and net income, which may influence how investors view its capital needs and future projects. We’ll now examine how this sizable...

Investors may be wondering if Prudential Financial at around US$100 a share still offers value, or if most of the opportunity has already been priced in. The stock last closed at US$100.27, with returns of 3.5% over the past week, 2.8% over the past month, 3.7% over the last year and 43.0% over three years. Year to date it is down 11.9% and up 21.6% over five years. Recent headlines have focused on Prudential Financial in the context of broader insurance sector sentiment and changing...